Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction
- PMID: 17200480
- DOI: 10.1001/jama.297.1.91
Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction
Comment in
-
Pexelizumab and the APEX AMI trial.JAMA. 2007 May 2;297(17):1881; author reply 1881-2. doi: 10.1001/jama.297.17.1881-b. JAMA. 2007. PMID: 17473297 No abstract available.
Comment on
-
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.JAMA. 2007 Jan 3;297(1):43-51. doi: 10.1001/jama.297.1.43. JAMA. 2007. PMID: 17200474 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
